Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The von Hippel-Lindau protein pVHL suppresses renal tumorigenesis in part by promoting the degradation of hypoxia-inducible HIF-alpha transcription factors; additional mechanisms have been proposed. pVHL also stabilizes the plant homeodomain protein Jade-1, which is a candidate renal tumour suppressor that may correlate with renal cancer risk. Here we show that Jade-1 binds the oncoprotein beta-catenin in Wnt-responsive fashion. Moreover, Jade-1 destabilizes wild-type beta-catenin but not a cancer-causing form of beta-catenin. Whereas the well-established beta-catenin E3 ubiquitin ligase component beta-TrCP ubiquitylates only phosphorylated beta-catenin, Jade-1 ubiquitylates both phosphorylated and non-phosphorylated beta-catenin and therefore regulates canonical Wnt signalling in both Wnt-off and Wnt-on phases. Thus, the different characteristics of beta-TrCP and Jade-1 may ensure optimal Wnt pathway regulation. Furthermore, pVHL downregulates beta-catenin in a Jade-1-dependent manner and inhibits Wnt signalling, supporting a role for Jade-1 and Wnt signalling in renal tumorigenesis. The pVHL tumour suppressor and the Wnt tumorigenesis pathway are therefore directly linked through Jade-1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, RPGRIP1L regulates WNT–PCP pathways by modulating DVL levels 212, 215.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [215]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529
Jho, E.-H., Zhang, T., Domon, C., Joo, C.-K., Freund, J.-N., & Costantini, F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1172-1183.2002 · Cited by 1,678
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
Self-citationNormal Table of Xenopus Laevis.
Johnson, K. E. (1968) · PubMed Central · Cited by 1,220
Wnt signaling in disease and in development
NUSSE, R. (2005) · Cell Research · doi:10.1038/sj.cr.7290260 · Cited by 973
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Simons, M., Gloy, J., Ganner, A., Bullerkotte, A., Bashkurov, M., Krönig, C., Schermer, B., Benzing, T., Cabello, O. A., Jenny, A., et al. (2005) · Nature Genetics · doi:10.1038/ng1552 · Cited by 767 · cited 1×
“Jade-1 and pVHL may also participate in other forms of cystic kidney disease, for which evidence of dysregulated Wnt signalling is increasin”
BackgroundHart, M., Concordet, J.-P., Lassot, I., Albert, I., del los Santos, R., Durand, H., Perret, C., Rubinfeld, B., Margottin, F., Benarous, R., et al. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80091-8 · Cited by 671 · cited 1×
“Endogenous β-TrCP resides in the cytosol and is capable of binding and ubiquitylating phosphorylated β-cateni”
BackgroundAn F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of β-catenin
Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, N., Hattori, K., Nakamichi, I., Kikuchi, A., Nakayama, K.-I., & Nakayama, K. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2401 · Cited by 530 · cited 1×
“Endogenous β-TrCP resides in the cytosol and is capable of binding and ubiquitylating phosphorylated β-cateni”
Background
Cited by
The many faces and functions of β‐catenin
Valenta, T., Hausmann, G., & Basler, K. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.150 · Cited by 1,598
“Dvl-mediated phosporylation of LRP5/6 by CK1 is key for proper functioning of the Wnt signalosome as it leads to a block of GSK3 kinase activity (Zeng et al , 2008).”
Cellular signalling by primary cilia in development, organ function and disease
Anvarian, Z., Mykytyn, K., Mukhopadhyay, S., Pedersen, L. B., & Christensen, S. T. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0116-9 · Cited by 845
The regulation of β-catenin activity and function in cancer: therapeutic opportunities
Shang, S., Hua, F., & Hu, Z.-W. (2017) · Oncotarget · doi:10.18632/oncotarget.15687 · Cited by 641
“β-Catenin Ser33 phosphorylation induced by GSK3β enhances its binding with Jade1 in the Wnt-off state [40].”
BackgroundEmerging roles of Wnts in the adult nervous system
Inestrosa, N. C., & Arenas, E. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2755 · Cited by 612
Autophagy negatively regulates Wnt signalling by promoting Dishevelled degradation
Gao, C., Cao, W., Bao, L., Zuo, W., Xie, G., Cai, T., Fu, W., Zhang, J., Wu, W., Zhang, X., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2082 · Cited by 389
Generating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 330
“Recent reports indicate that the hypoxic signalling cascade is interdigitated with other signalling mechanisms, such as Wn”
BackgroundGameiro, P. A., Yang, J., Metelo, A. M., Pérez-Carro, R., Baker, R., Wang, Z., Arreola, A., Rathmell, W. K., Olumi, A., López-Larrubia, P., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.02.002 · Cited by 325
“VHL has also been implicated in regulation of NF-κB signaling, tubulin polymerization, cilia biogenesis, and proper assembly of extracellular fibronectin (Chitalia et al., 2008; Kim and Kaelin, 2003; Ohh et al., 1998; Thoma et al., 2007; Yang et al., 2007).”
Wnt/β-catenin signalling: from plasma membrane to nucleus
Kim, W., Kim, M., & Jho, E.-H. (2013) · Biochemical Journal · doi:10.1042/bj20121284 · Cited by 313
Armadillo-repeat protein functions: questions for little creatures
Tewari, R., Bailes, E., Bunting, K. A., & Coates, J. C. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.05.003 · Cited by 259
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
Bian, J., Dannappel, M., Wan, C., & Firestein, R. (2020) · Cells · doi:10.3390/cells9092125 · Cited by 250
“Nuclear abundance pos TCF4 [35]; BCL9 [35]; PIN1 [36] neg NPHP4 [37]; JADE-1 [38]; c-CBL [39,40] Transcriptional activity pos FERMT1 [41]; AKT (Ser552) [42]; RTK (Tyr654) [43]; RTK (Tyr142) [44] neg SIRT1 [34]”
Regulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 226
A Clearer View of the Molecular Complexity of Clear Cell Renal Cell Carcinoma
Frew, I. J., & Moch, H. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040306 · Cited by 220
Signaling pathways in renal cell carcinoma
Banumathy, G., & Cairns, P. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.7.13247 · Cited by 221
Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients
Fendler, A., Bauer, D., Busch, J., Jung, K., Wulf-Goldenberg, A., Kunz, S., Song, K., Myszczyszyn, A., Elezkurtaj, S., Erguen, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14700-7 · Cited by 189
The VHL tumor suppressor: master regulator of HIF
Haase, V. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649394 · Cited by 175
“Zhou MI, Wang H, Foy RL, Ross JJ, Cohen HT. Tumor suppressor von Hippel-Lindau (VHL) stabilization of Jade-1 protein occurs through plant homeodomains and is VHL mutation dependent.”
BackgroundInfluentialIdentification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma
Morris, M. R., Ricketts, C., Gentle, D., Abdulrahman, M., Clarke, N., Brown, M., Kishida, T., Yao, M., Latif, F., & Maher, E. R. (2010) · Oncogene · doi:10.1038/onc.2009.493 · Cited by 174
“Recently, pVHL has been reported to regulate the p53 pathway (relevant to RPRM) and the Wnt/beta catenin pathway (downstream of SFRP1) by targeting beta catenin for proteasomal degradation (Chitalia et al., 2008).”
BackgroundRegulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers
Park, H.-B., Kim, J.-W., & Baek, K.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113904 · Cited by 169
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Xue, J., Chen, Y., Wu, Y., Wang, Z., Zhou, A., Zhang, S., Lin, K., Aldape, K., Majumder, S., Lu, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7156 · Cited by 160
USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth
An, T., Gong, Y., Li, X., Kong, L., Ma, P., Gong, L., Zhu, H., Yu, C., Liu, J., Zhou, H., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.011 · Cited by 142
Chitalia, V. C., Shivanna, S., Martorell, J., Balcells, M., Bosch, I., Kolandaivelu, K., & Edelman, E. R. (2012) · Circulation · doi:10.1161/circulationaha.112.118174 · Cited by 139
“TF degradation and stability were measured by TF half-life after blocking protein translation.(29) Uremic serum Figure 4.”
Self-citationCasein kinase 1α: biological mechanisms and theranostic potential
Jiang, S., Zhang, M., Sun, J., & Yang, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0236-z · Cited by 130
“The plant homeodomain zinc finger protein Jade-1 functions as an E3 ubiquitin ligase that ubiquitinates both phosphorylated and non-phosphorylated forms of β-catenin [35] and is a substrate of CK1α; it is phosphorylated at Ser18 and Ser20, which reduces its ability to inhibit Wnt/β-catenin signaling [36, 37].”
BackgroundA novel non‐coding RNA lncRNA‐JADE connects DNA damage signalling to histone H4 acetylation
Wan, G., Hu, X., Liu, Y., Han, C., Sood, A. K., Călin, G. A., Zhang, X., & Lu, X. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.221 · Cited by 140
“A recent study demonstrated that Jade1 binds and promotes the ubiquitination and destruction of b -catenin and inhibits canonical Wnt signalling (Chitalia et al , 2008).”
The epigenetic landscape of renal cancer
Morris, M. R., & Latif, F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.168 · Cited by 147
The role of ubiquitination and deubiquitination in the regulation of cell junctions
Cai, J., Culley, M. K., Zhao, Y., & Zhao, J. (2018) · Protein & Cell · doi:10.1007/s13238-017-0486-3 · Cited by 121
“…is responsible for the regulation of cytoplasmic phosphorylated β-catenin ubiquitination and degradation (Kitagawa et al., 1999; Latres et al., 1999), the Ub E3 ligase Jade-1 is believed to ubiquitinate both the phosphorylated and non-phosphorylated βcatenin in the nuclei (Chitalia et al., 2008).”
Chen, L., Han, L., Zhang, K., Shi, Z., Zhang, J., Zhang, A., Wang, Y., Song, Y., Li, Y., Jiang, T., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos122 · Cited by 122
“demonstrated that VHL acts through the E3 ubiquitin ligase Jade-1 to target b-catenin for proteasomal degradation.(36) The implication of this finding is that deregulated VHL provides growth stimulatory signals by activating oncogenic b-catenin signaling, while increasing the ability of the tumor to cope with limited…”
BackgroundDirect Ubiquitination of β-Catenin by Siah-1 and Regulation by the Exchange Factor TBL1
Dimitrova, Y. N., Li, J., Lee, Y.-T., Rios-Esteves, J., Friedman, D. B., Choi, H.-J., Weis, W. I., Wang, C.-Y., & Chazin, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049411 · Cited by 114
Avvakumov, N., Lalonde, M., Saksouk, N., Paquet, É. R., Glass, K. C., Landry, A.-J., Doyon, Y., Cayrou, C., Robitaille, G., Richard, D. E., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.06455-11 · Cited by 121
“Furthermore, while it has been argued that JADE1 is a direct repressor of Wnt signaling (6), we show here that HBO1 depletion leads to downregulation of repressors of the Wnt signaling pathway and upregulation of the frizzled receptors and BCL9, supporting a transcriptional role in modulating this pathway.”
BackgroundInfluentialDestabilizing LSD1 by Jade-2 Promotes Neurogenesis: An Antibraking System in Neural Development
Han, X., Gui, B., Xiong, C., Zhao, L., Liang, J., Sun, L., Yang, X., Yu, W., Si, W., Yan, R., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.006 · Cited by 111
“Furthermore, Jade-2 had no or only marginal effect on the expression of other histone modification enzymes or their cofactors, and LSD1 is not targeted by b-TRCP and Jade-1, the E3 ubiquitin ligases for REST and b-catenin, respectively (Chitalia et al., 2008; Westbrook et al., 2008) (Figures 3D–3F).”
BackgroundYang, F., Xu, J., Li, H., Tan, M., Xiong, X., & Sun, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-09289-5 · Cited by 109
The Ubiquitin-Proteasome System Meets Angiogenesis
Rahimi, N. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0555 · Cited by 115
USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization
Wu, C., Luo, K., Zhao, F., Yin, P., Song, Y., Deng, M., Huang, J., Chen, Y., Li, L., Lee, S., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0138-z · Cited by 102
The various roles of ubiquitin in Wnt pathway regulation
Tauriello, D. V. F., & Maurice, M. M. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13204 · Cited by 94
Ma, P., Yang, X., Kong, Q., Li, C., Yang, S., Li, Y., & Mao, B. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00731-14 · Cited by 93
Targeting the β-catenin signaling for cancer therapy
Zhang, X., Wang, L., & Qu, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104794 · Cited by 98
Cystic kidney disease: the role of Wnt signaling
Lancaster, M. A., & Gleeson, J. G. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.05.004 · Cited by 103
Forkhead Box F2 Suppresses Gastric Cancer through a Novel FOXF2–IRF2BPL–β-Catenin Signaling Axis
Higashimori, A., Dong, Y., Zhang, Y., Kang, W., Nakatsu, G., Ng, S. S. M., Arakawa, T., Sung, J. J. �., Chan, F. K. L., & Yu, J. Q. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2403 · Cited by 95
HIF-2α Enhances β-Catenin/TCF-Driven Transcription by Interacting with β-Catenin
Choi, H., Chun, Y.-S., Kim, T.-Y., & Park, J.-W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0505 · Cited by 79
Lavergne, E., Hendaoui, I., Coulouarn, C., Ribault, C., Leseur, J., Eliat, P., Mebarki, S., Corlu, A., Clément, B., & Musso, O. C. (2010) · Oncogene · doi:10.1038/onc.2010.432 · Cited by 87
Dere, R., Perkins, A. L., Bawa‐Khalfe, T., Jonasch, D., & Walker, C. L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090984 · Cited by 87
Hypoxia Inactivates the VHL Tumor Suppressor through PIASy-Mediated SUMO Modification
Cai, Q., Verma, S. C., Kumar, P., Ma, M., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009720 · Cited by 76
“pathway [15]; and stabilizing Jade-1 for proteasomal degradation of oncoprotein b-catenin [16].”
BackgroundGramicidin A: A New Mission for an Old Antibiotic
David, J. M., & Rajasekaran, A. K. (2015) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2015.21 · Cited by 82
“which preserves DNA damage responses and inhibits oncogenic Wnt/β-catenin signaling, respectively (40, 41).”
BackgroundLiu, W., Zhan, Z., Zhang, M., Sun, B., Shi, Q., Luo, F., Zhang, M., Zhang, W., Hou, Y., Xiao, X., et al. (2021) · Theranostics · doi:10.7150/thno.57455 · Cited by 74
“Recently, β-catenin has been reported to be ubiquitinated by other E3 ligases, such as TRIM33 [50], Jade-1 [51], Siah-1 [52] and c-Cbl [53].”
Backgroundc-Cbl targets PD-1 in immune cells for proteasomal degradation and modulates colorectal tumor growth
Lyle, C., Richards, S., Yasuda, K., Napoleon, M. A., Walker, J., Arinze, N. V., Belghasem, M., Vellard, I., Yin, W., Ravid, J. D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-56208-1 · Cited by 72
Self-citationEpigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
Morris, M. R., & Maher, E. R. (2010) · Genome Medicine · doi:10.1186/gm180 · Cited by 79
c-Cbl, a Ubiquitin E3 Ligase That Targets Active β-Catenin
Chitalia, V. C., Shivanna, S., Martorell, J., Meyer, R., Edelman, E. R., & Rahimi, N. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.473801 · Cited by 75
Self-citationChen, Y., Fang, R., Yue, C., Chang, G., Li, P., Guo, Q., Wang, J., Zhou, A., Zhang, S., Fuller, G. N., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1229 · Cited by 71
“To determine whether KDM4C regulation of these targets occurs in response to Wnt3a increasing or β-catenin activation, we ectopically expressed S33A β-catenin mutant, a naturally occurring and constitutively activation mutant (29).”
BackgroundWnt signaling pathways in urological cancers: past decades and still growing
Majid, S., Saini, S., & Dahiya, R. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-7 · Cited by 79
The role of ubiquitination in health and disease
Liao, Y., Zhang, W., Liu, Y., Zhu, C., & Zou, Z. (2024) · MedComm · doi:10.1002/mco2.736 · Cited by 95
Bryja, V., Červenka, I., & Čajánek, L. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1350135 · Cited by 76
Epigenetic stability, adaptability, and reversibility in human embryonic stem cells
Tompkins, J. D., Hall, C., Chen, V. C.-Y., Li, A. X., Wu, X., Hsu, D. S., Couture, L. A., & Riggs, A. D. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209620109 · Cited by 70
“The shared Mat/ mTR and CS/SP irreversible methylation gain was observed at the PHF17 (JADE-1) gene promoter, which is a candidate tumor suppressor in renal tumorigenesis through a Wnt-signaling connection (16).”
BackgroundArinze, N. V., Yin, W., Lotfollahzadeh, S., Napoleon, M. A., Richards, S., Walker, J., Belghasem, M., Ravid, J. D., Kamel, M. H., Whelan, S. A., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142260 · Cited by 71
“ECs expressing LS were exposed to these solutes at concentrations observed in CKD patients in absence (Wnt-off phase) or in presence of lithium chloride, a known inhibitor of GSK3β and Wnt activator (Wnt-on phase) (27, 28) (Supplemental Figure 7A).”
Self-citationEpigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma
Mehdi, A., & Riazalhosseini, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081774 · Cited by 70
“These cellular processes include glucose uptake and metabolism, angiogenesis [6,57], suppressing epithelial to mesenchymal transition (EMT) [24,58], cellular senescence [59], activating p53 [60], pH homeostasis, chemotaxis, proliferation, survival, apoptosis [6,57,61], transcription regulation [6], preventing aneuploi…”
BackgroundTran, H., Bustos, D. J., Yeh, R., Rubinfeld, B., Lam, C., Shriver, S. K., Zilberleyb, I., Lee, M. W., Phu, L., Sarkar, A. A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.415240 · Cited by 63
New Insights into the Biology of Renal Cell Carcinoma
Li, L., & Kaelin, W. G. (2011) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2011.04.004 · Cited by 71
“tumor suppressor protein Jade-1, which in turn is capable of targeting b-catenin for proteasomal degradation.(69) Finally, HIF1a itself modulates Wnt/b-catenin signaling in hypoxic embryonic stem (ES) cells by enhancing b-catenin activation and expression of the downstream effectors LEF-1 and TCF-1.”
BackgroundSmooth Muscle Cells Orchestrate the Endothelial Cell Response to Flow and Injury
Balcells, M., Martorell, J., Olivé, C., Santacana, M., Chitalia, V. C., Cardoso, A. A., & Edelman, E. R. (2010) · Circulation · doi:10.1161/circulationaha.109.877282 · Cited by 61
Self-citationChou, A. S. Y., Toon, C. W., Pickett, J., & Gill, A. J. (2013) · Frontiers of hormone research · doi:10.1159/000345668 · Cited by 67
Jeong, M., Piao, Z.-H., Kim, M. S., Lee, S. H., Yun, S., Sun, H.-N., Yoon, S. R., Chung, J. W., Kim, T.-D., Jeon, J. H., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804221 · Cited by 58
“It has been recently reported that -catenin is also subject to negative regulation by pVHL (33).”
BackgroundNew avenues to target Wnt/β-catenin signaling
Verkaar, F., & Zaman, G. J. R. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.11.007 · Cited by 64
Borgal, L., Habbig, S., Hatzold, J., Liebau, M. C., Dafinger, C., Sacarea, I., Hammerschmidt, M., Benzing, T., & Schermer, B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.385658 · Cited by 56
Lan, R., & Wang, Q. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03296-x · Cited by 59
“Besides, the cofactors of HBO1 complexes are found to act as E3 ligase, for example Jade-1 ubiquitylated β-catenin and mediated inhibition of the Wnt pathway [41].”
BackgroundUbiquitin/SUMO Modification Regulates VHL Protein Stability and Nucleocytoplasmic Localization
Cai, Q., & Robertson, E. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012636 · Cited by 65
“engages in regulation of the extracellular matrix [10,11], cellular differentiation [12], cell cycle [13], cell survival, apoptosis [14–16],”
BackgroundRetractedMidbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells
Ásgrímsdóttir, E. S., & Arenas, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00463 · Cited by 61
“…murine VM midline (Ono et al., 2007), as well as TOX, a transcriptional regulator of SOX2 (Artegiani et al., 2015), and JADE-1, an inhibitor of the Wnt signaling pathway Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 June 2020 | Volume 8 | Article 463 (Chitalia et al., 2008).”
BackgroundThe roles of ubiquitin modifying enzymes in neoplastic disease
Kumari, N., Jaynes, P. W., Saei, A., Iyengar, P. V., Richard, J. L. C., & Eichhorn, P. J. A. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.09.002 · Cited by 52
PHF7 Modulates BRDT Stability and Histone-to-Protamine Exchange during Spermiogenesis
Kim, C. R., Noda, T., Kim, H.-K., Kim, G., Park, S., Na, Y., Oura, S., Shimada, K., Bang, I., Ahn, J.-Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107950 · Cited by 46
Shivanna, S., Harrold, I., Shashar, M., Meyer, R., Kiang, C., Francis, J. M., Zhao, Q., Feng, H., Edelman, E. R., Rahimi, N., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616623 · Cited by 47
“The above data along with our previous work and that of others (10, 11, 16) support the following model.”
BackgroundMethodResultSelf-citationXu, G., Lu, X., Huang, T., & Fan, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10386 · Cited by 43
RetractedZhang, S., Zhou, X., Wang, B., Zhang, K., Liu, S., Yue, K., Zhang, L., & Wang, X. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.06.007 · Cited by 46
“Proteasome inhibition completely abrogated the effect of Jade-1 on b-catenin, provided compelling evidence that VHL play an important role in b-catenin degradation via ubiquitination [28,29].”
BackgroundUbiquitin pathways regulate the pathogenesis of chronic liver disease
Park, J.-S., Ma, H., & Roh, Y. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114764 · Cited by 43
WDR 26 is a new partner of Axin1 in the canonical Wnt signaling pathway
Goto, T., Matsuzawa, J., Iemura, S., Natsume, T., & Shibuyà, H. (2016) · FEBS Letters · doi:10.1002/1873-3468.12180 · Cited by 39
Sánchez-Morgan, N., Kirsch, K. H., Trackman, P. C., & Sonenshein, G. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01426-10 · Cited by 38
“To evaluate functional -catenin-mediated transactivation, we used the TOPFlash reporter that harbors six LEF-1/TCF-binding sites (4).”
MethodPolycystins as components of large multiprotein complexes of polycystin interactors
Hardy, E. P., & Tsiokas, L. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109640 · Cited by 40
“Jade-1 is a ubiquitin ligase for β-catenin [73] and has also been shown to bind the coiled-coil domain of PKD1 [74].”
BackgroundNeddylation is essential for β-catenin degradation in Wnt signaling pathway
Wang, B., Wang, T., Zhu, H., Yan, R., Li, X., Zhang, C., Tao, W., Ke, X., Hao, P., & Qu, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110538 · Cited by 40
Genome-wide association study and functional validation implicates JADE1 in tauopathy
Farrell, K. W., Kim, S., Han, N., Iida, M. A., Gonzalez, E. M., Otero‐García, M., Walker, J. M., Richardson, T. E., Renton, A. E., Andrews, S. J., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02379-z · Cited by 39
Self-citationD'Arceuil, H. E., Liu, C. H., Levitt, P. R., Thompson, B. L., Kosofsky, B. E., & de Crespigny, A. J. (2007) · Developmental Neuroscience · doi:10.1159/000110503 · Cited by 39
Cole, A. M., Ridgway, R. A., Derkits, S. E., Parry, L., Barker, N., Clevers, H., Clarke, A. R., & Sansom, O. J. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000101 · Cited by 37
“Importantly, this study showed the induction of senescence was hypoxia-inducible factor (HIF) independent and therefore may be due to increased levels of Wnt signalling following VHL loss (Behrens, 2008; Chitalia et al, 2008).”
BackgroundIizuka, M., Susa, T., Takahashi, Y., Tamamori‐Adachi, M., Kajitani, T., Okinaga, H., Fukusato, T., & Okazaki, T. (2013) · Cancer Science · doi:10.1111/cas.12303 · Cited by 35
Liu, X., Cai, X., Hu, B., Mei, Z., Zhang, D., Ouyang, G., Wang, J., Zhang, W., & Xiao, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745471 · Cited by 37
“Notably, the regulation of pVHL at the protein level through protein-protein interactions or posttranslational modifications has been revealed, which can affect VHL function in mediating its targets for proteasomal degradation (15, 31, 49).”
BackgroundFANCL ubiquitinates β-catenin and enhances its nuclear function
Dao, K.-H. T., Rotelli, M. D., Petersen, C. L., Kaech, S., Nelson, W. D., Yates, J. E., Newell, A. E. H., Olson, S. B., Druker, B. J., & Bagby, G. C. (2012) · Blood · doi:10.1182/blood-2011-11-388355 · Cited by 33
Renal cancer: Oxygen meets metabolism
Haase, V. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.026 · Cited by 38
“Chitalia VC, Foy RL, Bachschmid MM, Zeng L, Panchenko MV, Zhou MI, Bharti A, Seldin DC, Lecker SH, Dominguez I, Cohen HT. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL. Nat Cell Biol.”
BackgroundMinervini, G., Quaglia, F., Tabaro, F., & Tosatto, S. C. E. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006478 · Cited by 31
Chen, X., & Shi, W. (2020) · Apidologie · doi:10.1007/s13592-020-00760-7 · Cited by 31
Sato, A., Shimizu, M., Goto, T., Masuno, H., Kagechika, H., Tanaka, N., & Shibuyà, H. (2020) · Communications Biology · doi:10.1038/s42003-020-01386-2 · Cited by 36
Kumaradevan, S., Lee, S. Y., Richards, S., Lyle, C., Zhao, Q., Tapan, Ü., Jiangliu, Y., Ghumman, S., Walker, J., Belghasem, M., et al. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.05.007 · Cited by 32
Self-citationA Zebrafish Model for VHL and Hypoxia Signaling
van Rooijen, E., Santhakumar, K., Logister, I., Voest, E. E., Schulte‐Merker, S., Giles, R. H., & Eeden, F. V. (2011) · Methods in cell biology · doi:10.1016/b978-0-12-381320-6.00007-2 · Cited by 32
Xu, D., Li, F., Xue, G., Hou, K., Fang, W., & Li, Y. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.07.005 · Cited by 30
pVHL Mediates K63-Linked Ubiquitination of nCLU
Xue, J., Lv, D., Jiao, S., Zhao, W., Li, X., Sun, H., Yan, B., Fan, L., Hu, R., & Fang, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035848 · Cited by 26
“pVHL is also involved in regulation of NF-kB [15] and Wnt signaling [16].”
BackgroundRasmussen, N. R., Wright, T. M., Brooks, S. A., Hacker, K. E., Debebe, Z., Sendor, A. B., Walker, M. P., Major, M. B., Green, J., Wahl, G. M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.466086 · Cited by 28
The E3-ome gene-centric compendium reveals the human E3 ligase landscape
Chua, N. K., González-Robles, T. J., Reddington, C. J., Dudley-Fraser, J., Birkinshaw, R. W., Han, J., Solano, A. N., Wong, S. W., Kochańczyk, T., Peter, J. J., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.029 · Cited by 35
Structure, function and regulation of jade family PHD finger 1 (JADE1)
Panchenko, M. V. (2016) · Gene · doi:10.1016/j.gene.2016.05.002 · Cited by 27
Self-citationSynergistic Signaling of Tumor Cell Invasiveness by Hepatocyte Growth Factor and Hypoxia
Lee, Y. H., Morrison, B. L., & Bottaro, D. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580597 · Cited by 31
“Interestingly, this does not occur as a consequence of HIF accumulation but rather because pVHL negatively regulates cytoplasmic -catenin abundance downstream of HGF receptor (Met) activation, and pVHL loss enables -catenin and HIF-mediated transcriptional initiation of an aggressive invasive program (4, 5).”
BackgroundZhang, P., Bai, Y., Lu, L., Li, Y., & Duan, C. (2016) · eLife · doi:10.7554/elife.08996 · Cited by 29
“The b-catenin degradation induced by pVHL is dependent on the presence of Jade-1, an E3 ubiquitin ligase (Chitalia et al., 2008).”
BackgroundHe, H., Ding, F., Li, Y., Luo, A., Chen, H., Wu, C., & Liu, Z. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0419 · Cited by 28
“36), p-VHL/Jade-1 in renal cancer (37), and Ozz-E3–mediated degradation during myogenesis (38).”
BackgroundShashar, M., Siwak, J. F., Tapan, Ü., Lee, S. Y., Meyer, R., Parrack, P. H., Tan, J. N. M., Khatami, F., Francis, J. M., Zhao, Q., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12107 · Cited by 26
“com/oncotarget a protein translational blocker, which generates a kinetic profile of protein degradation from samples harvested at different time points [16, 29].”
Self-citationParsons, M. J., Grimm, C., Paya-Cano, J. L., Fernandes, C., Liu, L., Philip, V. M., Chesler, E. J., Nietfeld, W., Lehrach, H., & Schalkwyk, L. C. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-476 · Cited by 26
Dibus, N., Liďák, T., & C̆ermák, L. (2019) · Genes · doi:10.3390/genes10100815 · Cited by 30
“The stabilized Jade1 interacts with the β-catenin N-terminus and mediates its ubiquitination and degradation [70,71].”
BackgroundControl of Hedgehog Signalling by the Cilia-Regulated Proteasome
Gerhardt, C., Wiegering, A., Leu, T., & Rüther, U. (2016) · Journal of Developmental Biology · doi:10.3390/jdb4030027 · Cited by 26
“Additionally, the ubiquitin E3 ligase JADE-1, which is known to be involved in the ubiquitination of β-catenin [16], has been shown to be localised at the BB [17].”
BackgroundThe von Hippel–Lindau Tumor Suppressor Protein
Kaelin, W. G. (2018) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030617-050527 · Cited by 24
“Unfortunately, based on preclinical models and early clinical data, it is already clear that not all VHL−/− ccRCCs will respond to HIF2α antagonists (Chen et al. 2016, Cho et al. 2016).”
InfluentialThe natural agent rhein induces β‐catenin degradation and tumour growth arrest
Liu, S., Wang, J., Shao, T., Song, P., Kong, Q., Hua, H. M., Luo, T. L., & Jiang, Y. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13346 · Cited by 25
“Besides BTRC, Jade1 is another E3 ligase capable of inducing b-catenin degradation [29].”
BackgroundDuchi, S., Fagnocchi, L., Cavaliere, V., Hsouna, A., Gargiulo, G., & Hsu, T. (2010) · Development · doi:10.1242/dev.042804 · Cited by 24
“, 2008), protein stabilities (Chitalia et al., 2008; Roe and Youn, 2006) and tight junction formation (Calzada et al.”
BackgroundDrosophila von Hippel-Lindau Tumor Suppressor Gene Function in Epithelial Tubule Morphogenesis
Hsouna, A., Nallamothu, G., Kose, N., Guinea, M., Dammai, V., & Hsu, T. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01578-09 · Cited by 26
“It exhibits functions in matrix deposition (47), integrin processing (17), endocytosis (9, 27, 66), kinase adaptor (72), senescence (73), protein stability (10, 52), epithelial cell junction formation (4, 7, 23), and microtubule stability (24, 36), among many others (18).”
Background
Metadata
- Authors
- Chitalia, V. C., Foy, R. L., Bachschmid, M. M., Zeng, L., Panchenko, M. V., Zhou, M. I., Bharti, A., Seldin, D. C., Lecker, S. H., Dominguez, I., & Cohen, H. T.
- Affiliations
- Boston University (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cohen, Herbert T.
- ORCID
- Venue
- Nature Cell Biology
- Published
- 2008-09-21
- Volume
- 10
- Issue
- 10
- Pages
- 1208-1216
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- PMC
- PMC2830866
- OpenAlex
- W1979521719
- Cited by
- 182
- References
- 32
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 7 · 2020: 15 · 2019: 11 · 2018: 10 · 2017: 7 · 2016: 13 · 2015: 5 · 2014: 11 · 2013: 13 · 2012: 20
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01 CA 79830, R01 CA71796, R01CA079830, R01CA071796)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK067569, T32-DK07053, T32DK007053, R01 DK 67569)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Keywords
- von Hippel-Lindau protein, β-catenin, Wnt signaling, ubiquitination, E3 ubiquitin ligase, β-TrCP, renal tumorigenesis, kidney cancer, tumour suppressor, protein degradation
- MeSH terms
- Animals, Cell Line, Humans, Protein Binding, Xenopus, Signal Transduction, Homeodomain Proteins, Tumor Suppressor Proteins, Wnt Proteins, beta Catenin, Von Hippel-Lindau Tumor Suppressor Protein, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.